Zacks Small Cap Analysis – HCTI: 4Q25 Earnings Preview – M&A + Capital Reload + Buybacks – Cyber Tech

By Michael Kim

NASDAQ:HCTI

READ THE FULL HCTI RESEARCH REPORT

Forward of 4Q25/full-year 2025 outcomes prone to be introduced later this month, we spotlight a number of key strategic/monetary bulletins through the quarter, together with:

1. Strategic M&A: Following the preliminary announcement of a Letter of Intent (LOI) in October 2025, the corporate just lately disclosed the signing of a definitive settlement to accumulate sure belongings from Teyame AI LLC, a number one supplier of AI-powered Buyer Expertise (CX) options primarily based in Spain. Extra particularly, Teyame affords name middle/telemarketing, KPI reporting/information analytics, and advertising and marketing technique companies, together with omnichannel CX platforms leveraging Agentic AI, or autonomous methods incorporating Giant Language Fashions (LLMs) that independently plan/execute multi-step workflows. Stepping again, Teyame will seemingly transition right into a separate subsidiary of Healthcare Triangle (NASDAQ:HCTI), with administration targeted on cross-selling Teyame’s CX options to reinforce affected person engagement, in addition to leveraging Teyame’s presence in Spain to more and more penetrate the LatAm and European markets. Phrases of the transaction embody a complete consideration of as much as $50 million consisting of upfront money funds and shares of HCTI widespread inventory and convertible most well-liked inventory, in addition to an equity-based contingent earnout cost. From a monetary perspective, the transaction is prone to be extremely accretive on condition that the acquired belongings generated ~$32 million in income and ~$3.6 million in EBITDA in fiscal 2025.

2. Capital reload: From a financing perspective, administration just lately introduced a sequence of capital raises to fund the Teyame acquisition and supply working capital. Extra particularly, HCTI raised $4.0 million through the sale of 681,553 shares of widespread inventory at $5.81 per share underneath the corporate’s $20 million At-the-Market (ATM) providing program. Individually, the corporate issued $15 million of senior unsecured convertible notes, with an choice to difficulty an incremental $15 million of notes topic to investor approvals. The primary tranche of $7.5 million of notes closed in November 2025, with the second tranche issuable subsequent to an efficient registration assertion for the resale of associated shares.

3. More and more leveraging QuantumNexis: From an natural development standpoint, senior officers stay targeted on leveraging QuantumNexis, the corporate’s subsidiary offering digital psychological well being options and AI-powered Hospital Info Programs throughout Asia, the Center East, Africa, and Europe. More moderen initiatives embody: a) the launch of operations in Dubai to focus on high-growth markets in Gulf Cooperation Council (GCC) nations; b) a three way partnership with Golden Code Holdings in Saudi Arabia to capitalize on Saudi Imaginative and prescient 2030, the Kingdom’s digital healthcare transformation technique; c) a strategic partnership with TNG Digital, a funds and monetary companies platform in Malaysia, to market QuantumNexis’s digital psychological well being options; and d) a improvement partnership with Higher.care, a digital healthcare platform supplier, to seize incremental development alternatives throughout Europe, the Center East, and Africa.

4. Share repurchases: Following the latest 1:60 reverse inventory break up to regain compliance with Nasdaq itemizing necessities (bringing the variety of shares of widespread inventory excellent to 757K as of February 10, 2026), the Board introduced a $2 million share repurchase authorization. Whereas the timing and degree of potential share repurchases stay at administration’s discretion, we be aware the present authorization represents a substantial share of the inventory’s present market capitalization.

SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to obtain our articles and experiences emailed on to you every morning. Please go to our web site for added info on Zacks SCR. 

DISCLOSURE: Zacks SCR has acquired compensation from the issuer immediately, from an funding supervisor, or from an investor relations consulting agency, engaged by the issuer, for offering analysis protection for a interval of a minimum of one 12 months. Analysis articles, as seen right here, are a part of the service Zacks SCR gives and Zacks SCR receives funds totaling a most charge of as much as $50,000 yearly for these companies offered to or relating to the issuer. Full Disclaimer HERE.